PARP3

poly(ADP-ribose) polymerase family member 3, the group of Poly(ADP-ribose) polymerases

Basic information

Region (hg38): 3:51942344-51948867

Previous symbols: [ "ADPRTL3" ]

Links

ENSG00000041880NCBI:10039OMIM:607726HGNC:273Uniprot:Q9Y6F1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PARP3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PARP3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
34
clinvar
5
clinvar
3
clinvar
42
nonsense
1
clinvar
1
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 35 6 5

Variants in PARP3

This is a list of pathogenic ClinVar variants found in the PARP3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-51943369-C-T Benign (Apr 19, 2018)723089
3-51943413-C-T not specified Uncertain significance (Sep 01, 2021)2270802
3-51943443-C-T not specified Uncertain significance (May 03, 2023)2543170
3-51943470-A-T not specified Uncertain significance (Jul 16, 2021)2238052
3-51943476-G-T Benign (May 30, 2018)789986
3-51943496-C-T Benign (May 30, 2018)788969
3-51943522-G-A not specified Uncertain significance (Jul 14, 2021)2237433
3-51943531-G-A not specified Likely benign (Jun 28, 2022)2298502
3-51944131-G-A not specified Uncertain significance (Jun 22, 2023)2591280
3-51944175-C-G not specified Likely benign (Dec 28, 2023)3208757
3-51944191-A-G not specified Likely benign (May 04, 2022)2287501
3-51944213-G-A not specified Uncertain significance (Dec 15, 2023)3208758
3-51944397-T-C not specified Uncertain significance (Jan 03, 2022)2268707
3-51944450-T-C not specified Uncertain significance (Oct 20, 2023)3208759
3-51944495-C-T not specified Uncertain significance (Aug 23, 2021)2368648
3-51944536-C-T Likely benign (Jun 01, 2022)2653874
3-51944538-A-G not specified Uncertain significance (Dec 21, 2022)2338040
3-51944587-G-A Benign (May 18, 2018)775877
3-51944850-C-T not specified Uncertain significance (Aug 17, 2022)2308298
3-51944869-G-A not specified Uncertain significance (Feb 28, 2023)2490972
3-51945005-G-T not specified Uncertain significance (Mar 31, 2023)2531751
3-51945042-G-A not specified Uncertain significance (Jun 21, 2021)2233927
3-51945046-G-A not specified Uncertain significance (Aug 01, 2022)2389101
3-51945069-C-G not specified Uncertain significance (Dec 28, 2023)3208760
3-51945088-G-T not specified Uncertain significance (Dec 16, 2023)3208761

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PARP3protein_codingprotein_codingENST00000398755 116523
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.97e-140.057312438324271248120.00172
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3103013170.9510.00001843546
Missense in Polyphen9193.2220.976171128
Synonymous0.6441171260.9270.000007481022
Loss of Function0.5852326.20.8770.00000129297

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.007780.00776
Ashkenazi Jewish0.00009930.0000993
East Asian0.0002780.000278
Finnish0.00004640.0000464
European (Non-Finnish)0.001070.00105
Middle Eastern0.0002780.000278
South Asian0.005560.00547
Other0.0006650.000659

dbNSFP

Source: dbNSFP

Function
FUNCTION: Involved in the base excision repair (BER) pathway, by catalyzing the poly(ADP-ribosyl)ation of a limited number of acceptor proteins involved in chromatin architecture and in DNA metabolism. This modification follows DNA damages and appears as an obligatory step in a detection/signaling pathway leading to the reparation of DNA strand breaks. May link the DNA damage surveillance network to the mitotic fidelity checkpoint. Negatively influences the G1/S cell cycle progression without interfering with centrosome duplication. Binds DNA. May be involved in the regulation of PRC2 and PRC3 complex-dependent gene silencing. {ECO:0000269|PubMed:16924674}.;
Pathway
Base excision repair - Homo sapiens (human);Necroptosis - Homo sapiens (human);Apoptosis - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.0853

Intolerance Scores

loftool
0.947
rvis_EVS
0.8
rvis_percentile_EVS
87.69

Haploinsufficiency Scores

pHI
0.0324
hipred
N
hipred_score
0.437
ghis
0.451

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.124

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Parp3
Phenotype
homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
parp3
Affected structure
pectoral fin
Phenotype tag
abnormal
Phenotype quality
aplastic

Gene ontology

Biological process
telomere maintenance;DNA repair;double-strand break repair;protein ADP-ribosylation;positive regulation of DNA ligation;regulation of mitotic spindle organization;protein poly-ADP-ribosylation;negative regulation of telomerase RNA reverse transcriptase activity;protein localization to site of double-strand break
Cellular component
nucleus;nucleolus;centriole;site of double-strand break
Molecular function
catalytic activity;NAD+ ADP-ribosyltransferase activity;protein ADP-ribosylase activity